EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response

Lucie Pearce, Sean M Davidson, Derek M Yellon

Basic Research in Cardiology · 2021-12 · 116 (1)

DOI: 10.1007/s00395-021-00852-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Basic Research in Cardiology, online erschienen am 24.02.2021. Verfasst von Lucie Pearce und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Hatter Cardiovascular Institute, 67 Chenies Mews, London, WC1E 6HX, UK. Hauptthemen laut MEDLINE: Immunity, Innate, Ischemic Preconditioning, Myocardial. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, NIHR-BRC, The Hatter Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The benefits of remote ischaemic conditioning (RIC) have been difficult to translate to humans, when considering traditional outcome measures, such as mortality and heart failure. This paper reviews the recent literature of the anti-inflammatory effects of RIC, with a particular focus on the innate immune response and cytokine inhibition. Given the current COVID-19 pandemic, the inflammatory hypothesis of cardiac protection is an attractive target on which to re-purpose such novel therapies. A PubMed/MEDLINE™ search was performed on July 13th 2020, for the key terms RIC, cytokines, the innate immune system and inflammation. Data suggest that RIC attenuates inflammation in animals by immune conditioning, cytokine inhibition, cell survival and the release of anti-inflammatory exosomes. It is proposed that RIC inhibits cytokine release via a reduction in nuclear factor kappa beta (NF-κB)-mediated NLRP3 inflammasome production. In vivo, RIC attenuates pro-inflammatory cytokine release in myocardial/cerebral infarction and LPS models of endotoxaemia. In the latter group, cytokine inhibition is associated with a profound survival benefit. Further clinical trials should establish whether the benefits of RIC in inflammation can be observed in humans. Moreover, we must consider whether uncomplicated MI and elective surgery are the most suitable clinical conditions in which to test this hypothesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateIschemic Preconditioning, MyocardialAnimalsCOVID-19Cell SurvivalCytokinesExtracellular VesiclesHumansImmunity, HumoralInflammationMyocardial Reperfusion Injury

Stichwörter der Autor:innen

CytokinesInflammationMyocardial infarctionRemote ischaemic conditioning

Substanzen

Cytokines

Autor:innen und Institutionen

  • The Hatter Cardiovascular Institute, 67 Chenies Mews, London, WC1E 6HX, UK.
  • The Hatter Cardiovascular Institute, 67 Chenies Mews, London, WC1E 6HX, UK. d.yellon@ucl.ac.uk.

Förderung

  • British Heart Foundation
  • NIHR-BRC
  • The Hatter Foundation

Zitieren

APA

Pearce, L., Davidson, S. M., & Yellon, D. M. (2021). Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response. Basic Research in Cardiology, 116(1). https://doi.org/10.1007/s00395-021-00852-0

Vancouver

Pearce L, Davidson SM, Yellon DM. Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response. Basic Research in Cardiology. 2021;116(1). doi:10.1007/s00395-021-00852-0

BibTeX
@article{Pearce2021,
  author = {Pearce, Lucie and Davidson, Sean M and Yellon, Derek M},
  title = {Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response},
  journal = {Basic Research in Cardiology},
  year = {2021},
  volume = {116},
  number = {1},
  doi = {10.1007/s00395-021-00852-0}
}
Kostenlos starten →